8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
Baxter reports 5% second-quarter sales growth and raises 2026 outlook
Filed with the SEC on · Summarized by InvestorsBot
Baxter reported second-quarter 2026 sales of $2.96 billion, up 5% on both a reported and organic basis, with U.S. GAAP diluted EPS of $0.26 and adjusted diluted EPS of $0.56. The company raised its full-year outlook to 3%-4% reported sales growth, 2%-3% organic sales growth and adjusted diluted EPS of $1.95-$2.15, citing operating performance and a $0.11-per-share benefit from an IEEPA tariff refund. Baxter’s board also declared a quarterly dividend of $0.01 per share, payable October 1, 2026, to shareholders of record August 28, 2026.